NEAT1 lncRNA and amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss.
• Key pathologies involve RNA-binding proteins like TDP-43 and FUS/TLS, and genetic factors including C9orf72 repeat expansions.
• The roles of specific RNA molecules and repeat expansions in ALS pathogenesis are complex and debated.

Purpose of the Study:

• To review the dual role of NEAT1 RNA and C9orf72 GGGGCC repeats in ALS.
• To analyze the transition of these factors from protective to toxic in disease progression.
• To provide a basis for developing novel RNA-targeted ALS therapies.

Main Methods:

• Literature review of recent findings on NEAT1 RNA and C9orf72 GGGGCC repeats in ALS.
• Analysis of studies investigating molecular mechanisms in ALS models.
• Synthesis of evidence regarding the stage-specific effects of these RNA species.

Main Results:

• NEAT1 RNA and C9orf72 GGGGCC repeats may exhibit protective functions in the nucleus during early ALS phases.
• These elements can transition to inducing cell death in later stages of ALS.
• Dipeptide repeat proteins (DPRs) from C9orf72 expansions contribute to nuclear dysfunction.

Conclusions:

• Understanding the dynamic roles of NEAT1 RNA and C9orf72 repeats is crucial for ALS research.
• Targeting RNA effectors presents a promising avenue for novel ALS therapeutic strategies.
• Further investigation into the protective-to-toxic conversion is warranted for effective treatment development.